OVPENS Platform
Pipeline
Developing Products That are
Potent, Enabling, Novel and Safe
Potent, Enabling, Novel and Safe
-
Open VectorDual vector strategy which integrates both HSV-1 and exosome -
PotentCommitment to engineering novel vectors with exceptional efficacy -
EnablingCapability to drive synergistic combination therapies -
NovelInnovative, pioneering approach to parallel oncolytic immunotherapy and engineered exosome development -
SafeBio-derived vectors to exhibit favorable tolerability profiles
